Invention Grant
- Patent Title: Histone deacetylase inhibitors
- Patent Title (中): 组蛋白脱乙酰酶抑制剂
-
Application No.: US13843261Application Date: 2013-03-15
-
Publication No.: US08957066B2Publication Date: 2015-02-17
- Inventor: Vincent Jacques , James R Rusche , Norton P. Peet , Jasbir Singh
- Applicant: Repligen Corporation
- Applicant Address: US CA Novato
- Assignee: Biomarin Pharmaceutical Inc.
- Current Assignee: Biomarin Pharmaceutical Inc.
- Current Assignee Address: US CA Novato
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: C07D513/04
- IPC: C07D513/04 ; C07D471/04 ; C07D231/12 ; C07D403/06 ; C07D401/06 ; C07D471/08 ; C07D261/08 ; C07D263/32 ; C07D277/34 ; C07D211/70 ; C07D305/10 ; C07D205/06
Abstract:
This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3) using compounds of formula (I), wherein the substituents are as defined herein.
Public/Granted literature
- US20130317003A1 Histone Deacetylase Inhibitors Public/Granted day:2013-11-28
Information query
